Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Advanced Biologics LLC Stories

2013-04-29 08:28:06

LADERA RANCH, Calif., April 29, 2013 /PRNewswire/ -- Advanced Biologics announced today that they will be presenting expanded data at the American Academy of Neurosurgeons (AANS) meeting this week in New Orleans, LA showcasing a clinical study demonstrating superior lumbar fusion rates for OsteoAMP® when compared to rhBMP-2 (Infuse®, Medtronic). In a blinded, multi-center clinical and radiological study, fusion analysis showed superiority for OsteoAMP® in producing fusions when...

2012-10-25 07:32:39

LADERA RANCH, Calif., Oct. 25, 2012 /PRNewswire/ -- Advanced Biologics announced today that is has validated the OsteoAMP process showing no clinically relevant 'donor to donor' variation. The OsteoAMP® validation used >100 consecutive allograft donors that were processed into products which resulted in 100% clinical success in >300 lumbar and cervical spine fusions. Clinical success was determined by fusion rates radiologically assessed via x-ray and CT by a blinded,...

2012-10-22 07:30:11

LADERA RANCH, Calif., Oct. 22, 2012 /PRNewswire/ -- Advanced Biologics announced today that they will be releasing data at the North American Spine Society (NASS) annual meeting this week in Dallas, TX showcasing a clinical study demonstrating superior lumbar fusion rates for OsteoAMP® when compared to rhBMP-2 (Infuse®, Medtronic). In a blinded, multi-center clinical and radiological study, fusion analysis of 221 patients showed superiority for OsteoAMP® in producing fusions when...

2012-04-16 02:27:56

LADERA RANCH, Calif., April 16, 2012 /PRNewswire/ -- Advanced Biologics announced today that they will be presenting data at the American Academy of Neurosurgeons (AANS) meeting this week in Miami, FL showcasing a clinical study demonstrating superior lumbar fusion rates for OsteoAMP(®) when compared to rhBMP-2 (Infuse(®), Medtronic). In a blinded, multi-center clinical and radiological study, fusion analysis showed superiority for OsteoAMP(®) in producing fusions when compared...

2012-04-10 02:27:50

LADERA RANCH, Calif., April 10, 2012 /PRNewswire/ -- Advanced Biologics announced today that its OsteoAMP® product platform has been awarded a supplier contract with the Premier Healthcare Alliance. Effective July 1st, 2012, the agreement makes the revolutionary osteobiologic line available to Premier's 2500+ hospital members. OsteoAMP® is an award-winning allogeneic growth factor that is a lower-cost alternative to recombinant growth factors, such as rhBMP-2 (Infuse®,...

2011-11-02 07:00:00

LADERA RANCH, Calif., Nov. 2, 2011 /PRNewswire/ -- Advanced Biologics, (www.advancedbiologics.com) announced today that OsteoAMP® Structural has been awarded with a "Best New Technology for Spine Care in 2011" by Orthopedics This Week, Spine Technology Awards. This is Advanced Biologics' third Orthopedics This Week Spine Technology Award in a row as they have claimed awards at both the 2009 and 2010 awards ceremonies. OsteoAMP Structural is the first load-bearing,...

2011-11-01 07:00:00

LADERA RANCH, Calif., Nov. 1, 2011 /PRNewswire/ -- Advanced Biologics, (www.advancedbiologics.com) announced today that they will be launching the newest product within the OsteoAMP(® )platform during the North American Spine Society (NASS) annual meeting this week in Chicago, IL. OsteoAMP Structural is the first load-bearing, mineralized, osteoconductive allograft spacer that demonstrates osteoinductive properties in-vivo. Initial product offerings will include both...